AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Arcus Biosciences, Inc. Director's Dealing 2019

Mar 25, 2019

31966_dirs_2019-03-25_c431835b-8324-4456-addd-cbc7bcccf266.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2019-03-25

Reporting Person: Hemrajani Rekha (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25252	Indirect